title: [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
abstract: Sneddon's syndrome consists of livedo reticularis and cerebral vascular accidents with no evidence of systemic disease responsible for the livedo. The syndrome has been assimilated to a subgroup of systemic lupus erythematosus (SLE) with presence of antibodies directed against phospholipids. Recently, a significant increase in the frequency of cardiac valve diseases has been demonstrated in some SLE patients with livedo reticularis, cerebral vascular accidents and antiphospholipid antibodies. We report the case of a 26-year old woman who had been presenting for 6 years with idiopathic livedo reticularis. Her history was remarkable for the occurrence of 2 cerebral ischaemic accidents at the ages of 23 and 26 years, generalized convulsive seizures at 22 years, and hypertension of pregnancy with 2 miscarriages. Biopsy of the livedo showed normal histological patterns, but electron microscopy detected an obliterating endothelial proliferation and endothelial cells with numerous Weibel-Palade bodies. Laboratory signs of SLE, as well as antiphospholipid antibodies were absent. At the age of 26 years, cardiac abnormalities were heard at auscultation for the first time, and echocardiography showed that they were due to a fairly loose mitral stenosis. According to Burton's criteria our patient had all the typical features of Sneddon's syndrome. The finding of mitral stenosis--an emboligenic cardiopathy that is potentially responsible for cerebral vascular accidents--raises the problem of its relationship with Sneddon's syndrome. The association does not seem to be fortuitous, since our case is very similar to the cases of SLE or antiphospholipid antibody syndrome associated with cardiac valve lesions. However, this case is particular in that 6 years after the onset of the disease there was still no sign of SLE and of antiphospholipid antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service de Dermatologie, CHU Trousseau, Tours.
authors.forename: L
authors.initials: L
authors.lastname: Vaillant
authors.forename: P
authors.initials: P
authors.lastname: Larmande
authors.forename: B
authors.initials: B
authors.lastname: Arbeille
authors.forename: B
authors.initials: B
authors.lastname: Desveaux
authors.forename: Y
authors.initials: Y
authors.lastname: Gruel
authors.forename: G
authors.initials: G
authors.lastname: Lorette
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008946:Mitral Valve Stenosis / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D010743:Phospholipids / Q000276:immunology; D012871:Skin Diseases / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D013577:Syndrome; D014652:Vascular Diseases / Q000150:complications / Q000209:etiology
chemical_list: D000925:Anticoagulants; D001323:Autoantibodies; D010743:Phospholipids
vernacular_title: Livedo reticularis, accidents vasculaires cérébraux et maladie mitrale: une nouvelle cause du syndrome de Sneddon?